Chimeric antigen receptor T cell therapy reduces vaccine immunity, with many patients lacking seroprotection despite stable antibody levels.

Massive hepatic necrosis (MHN) represents the most severe pathological form of acute liver failure (ALF), with high mortality ...

Vaccines and other immune-based interventions are among the most effective strategies for preventing and controlling disease. However, their development is ...

Researchers at BITS Pilani Hyderabad Campus develop experimental vaccine against Streptococcus pneumoniae, offering hope for ...

Learn what the Nipah virus is, how it spreads, and why it has one of the highest fatality rates among infectious diseases.

Immune checkpoint inhibitors have reshaped cancer treatment over the past decade, but the same immune activation that shrinks tumors can also turn against healthy tissue, including the brain. A ...

Precigen (NASDAQ:PGEN) executives used a fireside chat hosted by H.C. Wainwright to outline the company’s transition into a commercial-stage organization following the FDA approval of Papzimeos, the ...

University of York researchers have identified a protein called ESB2 that functions as a “molecular shredder” inside the ...

Hørsholm, Denmark, 7 April 2026 - The Board of Directors of ExpreS2ion Biotech Holding AB (publ) ("ExpreS2ion" or the "Company") has today, on 7 April 2026, pursuant to the authorization granted by th ...

CK Life Sciences’ Sequencio Therapeutics Presents the Latest Vaccine Research Advancements at the American Association for Cancer Research Annual Meeting ...

Discusses Launch and Differentiation of PAPZIMEOS Immunotherapy for Adult RRP March 31, 2026 11:00 AM EDTCompany ...